ForeverLabs
ServicesProvidersScienceMission
Schedule your free consultation

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

K

Latest Articles

Active Filters:
Tag: Neurodegeneration
AI generated image for: Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease
Clinical
Aug 11, 2025
1 min read
PubMed
Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease
Intravenous transplantation of bone marrow-derived mononuclear cells (BMMCs) successfully improved cognitive function and prevented neurodegeneration in two different Alzheimer's disease mouse models.
NeurologyCognitive FunctionAmyloid BetaNeurodegenerationALZ / AlzheimersBone Marrow

Stay in touch

Shop

Annual planLifetime planClient LoginScheduler Login

Learn

ArticlesBlogPodcastFAQ

Careers

About usPrivacy policyPressTerms of Use

Questions

For physiciansPartner with usCareersContact us(888) 732-2375
ForeverLabs

FDA and Stem Cell Therapies

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review.